Teva considering cutting up to 10,000 jobs: Report

Dec 8, 2017

Share

Teva Pharmaceutical Industries Ltd (TEVA.N), the world's largest maker of generic drugs, is considering cutting up to 10,000 jobs, Bloomberg News reported on Friday.

Israel-based Teva wants to cut costs by US$1.5 billion to US$2 billion over the next two years, Bloomberg said, citing people with knowledge of the matter.